Rejuvenation of the aging chest: A review and our experience

Dermatologic Surgery

Volumn 37, Issue 5, 2011, Pages 555-571

  Peterson, Jennifer D ^a   Goldman, Mitchel P ^a  

^a Dermatology & Cosmetic Laser Associates of La Jolla   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BICARBONATE; BOTULINUM TOXIN A; COLLAGEN; DERMATOLOGICAL AGENT; GELATINASE A; GLYCOLIC ACID; HYALURONIC ACID; INTERSTITIAL COLLAGENASE; ISOTRETINOIN; JESSNERS SOLUTION; LIDOCAINE; PHENOL; POLIDOCANOL; POLYLACTIC ACID; RESORCINOL; SALICYLIC ACID; SODIUM CHLORIDE; STERILE WATER; TETRADECYL SULFATE SODIUM; TRICHLOROACETIC ACID; UNCLASSIFIED DRUG;

ABLATIVE FRACTIONATED LASER; ACNE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APPLICATION SITE ERYTHEMA; APPLICATION SITE HYPERPIGMENTATION; APPLICATION SITE PAIN; BREAST FEEDING; CARBON DIOXIDE LASER; CHEST TIGHTNESS; CHLOASMA; COLLAGEN SYNTHESIS; COUGHING; DILUTION; DRUG ABSORPTION; DRUG BINDING SITE; DRUG CONTRAINDICATION; DRUG ERUPTION; DRUG FORMULATION; DRUG INFORMATION; DRUG PENETRATION; DRUG SAFETY; ECCHYMOSIS; ERBIUM YAG LASER; ERYTHEMA; EXPECTATION; FOAM SCLEROTHERAPY; FUNNEL CHEST; HEADACHE; HEMATOMA; HUMAN; HYPERPIGMENTATION; HYPERTRICHOSIS; HYPERTROPHY; IMMUNE DEFICIENCY; INJECTION SITE; INJECTION SITE CONTUSION; INJECTION SITE EDEMA; INJECTION SITE INFLAMMATION; INJECTION SITE NODULE; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE REACTION; INTENSE PULSE LIGHT; KELOID; KERATOLYSIS; LIPOATROPHY; LOW LEVEL LASER THERAPY; MASSAGE; MEDLINE; MIGRAINE; MUSCLE HYPOTONIA; NONABLATIVE FRACTIONATED LASER; PATIENT ATTITUDE; PATIENT EDUCATION; PHOTOAGING; PHOTODERMATOSIS; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PREGNANCY; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; PURPURA; RECOMMENDED DRUG DOSE; REJUVENATION; RETICULAR CHEST VEIN; REVIEW; RHYTIDE; SCAR FORMATION; SCLEROTHERAPY; SKIN ALLERGY; SKIN ATROPHY; SKIN BURNING SENSATION; SKIN CARE; SKIN COLOR; SKIN DEFECT; SKIN DISEASE; SKIN EDEMA; SKIN INFECTION; SKIN PAIN; SKIN PENETRATION; SKIN PROTECTION; SKIN PRURITUS; SKIN SCAR; SKIN ULCER; SWITCHED LASER; SYSTEMATIC REVIEW; TELANGIECTASIA; THORAX DEFORMITY; THORAX DISEASE; TRANSIENT ISCHEMIC ATTACK; TREATMENT PLANNING; URTICARIA; VISUAL DISORDER;

ATROPHY; COSMETIC TECHNIQUES; HUMANS; HYPERPIGMENTATION; REJUVENATION; SKIN AGING; TELANGIECTASIS; THORAX; ULTRAVIOLET RAYS;

EID: 79955478455     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2011.01972.x     Document Type: Review

References (85)

1. Campbell TM, Goldman MP., Adverse events of fractionated carbon dioxide laser: review of 373 treatments. 2010; 36: 1645-50.
2. Butterwick K, Lowe NJ., Injectable poly-L-lactic acid for cosmetic enhancement: learning from the European experience. J Am Acad Dermatol 2009; 61: 281-93.
3. Vleggaar D., Soft-tissue augmentation and the role of poly-l-lactic acid. Plast Reconstr Surg 2006; 118: S46-54.
4. Palm MD, Woodhall KE, Butterwick KJ, Goldman MP., Cosmetic use of poly-l-lactic acid: a retrospective study of 130 patients. Dermatol Surg 2010; 36: 161-70.
5. Lam SM, Azizzadeh B, Graivier M., Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg 2006; 118: S55-63.
6. Mazzuco R, Hexsel D., Poly-L-lactic acid for neck and chest rejuvenation. Dermatol Surg 2009; 35: 1228-37.
7. Schulman MR, Lipper J, Skolnik RA., Correction of chest wall deformity after implant-based breast reconstruction using poly-L-lactic acid (Sculptra). Breast J 2008; 14: 92-6.
8. Narins RS., Minimizing adverse events associated with poly-L-lactic acid injection. Dermatol Surg 2008; 34: S100-4. (Pubitemid 351792858)
9. Fitzgerald R, Vleggaar D., Using poly-L-lactic acid (PLLA) to mimic volume in multiple tissue layers. J Drugs Dermatol 2009; 8: S5-14.
10. (Accessed July 2010).
11. (Accessed July 2010).
12. Becker-Wegerich PM, Rauch L, Ruzicka T., Botulinum toxin A: successful décolleté rejuvenation. Dermatol Surg 2002; 28: 168-71.
13. Ascher B, Talarico S, Cassuto D, Escobar S, et al,. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)-part II: wrinkles on the middle and lower face, neck and chest. J Eur Acad Dermatol Venereol 2010; 24: 1285-95.
14. Bowes LE, Goldman MP., Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest. Dermatol Surg 2002; 28: 46-51. (Pubitemid 34101581)
15. Jia X, Mowat G, Burr JM, Cassar K, et al,. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007; 94: 925-36. (Pubitemid 47236534)
16. Goldman MP, Bergan JJ, Geux JJ, Weiss RA., Sclerotherapy: Treatment of Varicose and Telangiectatis Leg Veins. 4th ed. Philadelphia: Elsevier; 2007.
17. Gillet JL, Guedes JM, Guex JJ, et al,. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1,025 patients. Phlebology 2009; 24: 131-8.
18. Palm MD, Guiha IC, Goldman MP., Foam sclerotherapy for reticular veins and nontruncal varicose veins of the legs: a retrospective review of outcomes and adverse effects. Dermatol Surg 2010; 38: 1026-33.
19. Landau M., Chemical peels. Clin Dermatol 2008; 26: 200-8. (Pubitemid 351620988)
20. Karam P., 50% resorcinol peel. Int J Dermatol 1993; 32: 569-74. (Pubitemid 23274582)
21. Collins PS., The chemical peel. Clin Dermatol 1987; 5: 57-74.
22. Cook K, Cook W., Chemical peel of nonfacial skin using a glycolic acid gel augmented with TCA and neutralized based on visual staging. Dermatol Surg 2001; 26: 994-9.
23. Obagi ZE, Obagi S, Alaiti S, Stevens MB,. TCA-based blue peel: a standardized procedure with depth control. Dermatol Surg 1999; 25: 773-80.
24. Clark E, Scerri L., Superficial and medium-depth chemical peels. Clin Dermatol 2008; 26: 209-18. (Pubitemid 351620990)
25. Kligman D, Kligman AM., Salicylic acid peels for the treatment of photoaging. Dermatol Surg 1998; 24: 325-8. (Pubitemid 28150891)
26. Zakopoulou N, Kontochristopoulos G., Superficial chemical peels. J Cosmet Dermatol 2006; 5: 246-53. (Pubitemid 44314388)
27. Fischer TC, Perosino E, Poli F, Viera MS, et al,. Chemical peels in aesthetic dermatology: an update 2009. J Eur Acad Dermatol Venereol 2010; 24: 281-92.
28. Grimes PE., The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 1999; 25: 18-22. (Pubitemid 29242727)
29. Swinehart JM., Salicylic acid ointment peeling of the hands and forearms: effective nonsurgical removal of pigmented lesions and actinic damage. J Dermatol Surg Oncol 1992; 18: 495-8.
30. Cox SE., Rapid development of keratoacanthomas after a body peel. Dermatol Surg 2003; 29: 201-3.
31. Collins PS., Trichloroacetic acid peels revisited. J Dermatol Surg Oncol 1989; 15: 933-40. (Pubitemid 19256572)
32. Weiss RA, Goldman MP, Weiss MA., Treatment of poikiloderma of Civatte with an intense pulsed light source. Dermatol Surg 2000; 26: 823-8.
33. Goldman MP, Weiss RA, Weiss MA., Intense pulsed light as a nonablative approach to photoaging. Dermatol Surg 2005; 31: 1179-87. (Pubitemid 41587067)
34. Bitter PH., Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg 2000; 26: 835-42.
35. Prieto VG, Sadick NS, Lloreta J, Nicholson J, et al,. Effects of intense pulsed light on sun-damaged human skin, routine, and ultrastructural analysis. Lasers Surg Med 2002; 30: 82-5.
36. Goldberg DJ., New collagen formation after dermal remodeling with an intensed pulsed light. J Cut Laser Ther 2000; 2: 59-61.
37. Negishi K, Wakamastu S, Kushikata N, Tezuka Y, et al,. Full-face photorejuvination of photodamaged skin by intense pulsed light with integrated contact cooling: initial experiences in Asian patients. Lasers Surg Med 2002; 30: 298-305. (Pubitemid 34438563)
38. Alam M, Hsu TS, Dover JS, Wrone DA, et al,. Nonablative laser and light treatments: histology and tissue effects-a review. Lasers Surg Med 2003; 33: 30-9.
39. Iyer S, Carranza D, Kolodney, Macgregor D, et al,. Evaluation of procollagen I deposition after intense pulsed light treatments at varying parameters in a porcine model. J Cosmet Laser Ther 2007; 9: 75-8. (Pubitemid 46897784)
40. Chen GS, Lin HC, Wu MT., Intense pulsed light irradiation may reverse activator protein-1 expression induced by ultraviolet light. J Am Acad Dermatol 2009; 61: 528-9.
41. Weiss RA, Weiss MA, Beasley KL., Rejuvenation of photoaged skin: 5 years results with intense pulsed light of the face, neck, and chest. Dermatol Surg 2002; 28: 1115-9.
42. Lowe NJ, Lowe P., Pilot study to determine the efficacy of ALA-PDT photo-rejuvenation for the treatment of facial ageing. J Cosmet Laser Ther 2005; 7: 159-62. (Pubitemid 43111916)
43. Dover JS, Bhatia AC, Stewart B, Arndt KA., Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging. Arch Dermatol 2005; 141: 1247-52. (Pubitemid 41498922)
44. Gold MH, Bradshaw VL, Boring MM, Bridges TM, et al,. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg 2006; 32: 795-801. (Pubitemid 43847114)
45. Touma D, Yaar M, Whitehead S, Konnikov N, et al,. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 2004; 140: 33-40. (Pubitemid 38090268)
46. Zane C, Capezzera R, Sala R, Venturini M, et al,. Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin. Lasers Surg Med 2007; 39: 203-9. (Pubitemid 46623029)
47. Ruiz-Rodrỳguez R, Lopez L, Candelas D, Pedraz J., Photorejuvenation using topical 5-methyl aminolevulinate and red light. J Drugs Dermatol 2008; 7: 633-7.
48. Avram DK, Goldman MP., Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol 2004; 1: S36-9.
49. Key DJ., Aminolevulinic acid-pulsed dye laser photodynamic therapy for the treatment of photoaging. Cosmet Dermatol 2005; 18: 31-6. (Pubitemid 40129314)
50. Orringer JS, Hammerberg C, Hamilton T, Johnson TM, et al,. Molecular effects of photodynamic therapy for photoaging. Arch Dermatol 2008; 144: 1296-302.
51. Marmur ES, Phelps R, Goldberg DJ., Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther 2005; 7: 21-4. (Pubitemid 40896747)
52. Goldman MP., Photodynamic Therapy. 2nd Ed. Philadelphia: Elsevier; 2008.
53. Goldman MP., Cutaneous and Cosmetic Laser Surgery. Philadelphia: Elsevier; 2006.
54. Kilmer SL, Garden JM., Laser treatment of pigmented lesions and tattoos. Semin Cutan Med Surg 2000; 19: 232-44. (Pubitemid 32042978)
55. Tse Y, Levine VJ, McClain SA, Ashinoff R., The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched neodymium: yttrium-aluminum-garnet laser. A comparative study. J Dermatol Surg Oncol 1994; 20: 795-800.
56. Lee MC, Hu S, Chen MC, Shih YC, et al,. Skin rejuvenation with 1,064-nm Q-switched Nd:YAG laser in Asian patients. Dermatol Surg 2009; 35: 929-32.
57. Goldberg DJ, Silapunt S., Histologic evaluation of a Q-switched Nd:YAG laser in the nonablative treatment of wrinkles. Dermatol Surg 2001; 27: 744-6. (Pubitemid 32738244)
58. Goldberg DJ, Silapunt S., Q-switched Nd:YAG laser: rhytid improvement by non-ablative dermal remodeling. J Cutan Laser Ther 2000; 2: 157-60.
59. Goldberg DJ, Whitworth J., Laser skin resurfacing with the Q-switched Nd:YAG laser. Dermatol Surg 1997; 23: 903-6.
60. Sadighha A, Saatee S, Muhaghegh-Zahed G., Efficacy and adverse effects of Q-switched ruby laser on solar lentigines: a prospective study of 91 patients with Fitzpatrick skin type II, III, and IV. Dermatol Surg 2008; 34: 1465-8.
61. Jang KA, Chung EC, Choi JH, et al,. Successful removal of freckles in Asian skin with a Q-switched alexandrite laser. Dermatol Surg 2000; 26: 231-4.
62. Manstein D, Herron GS, Sink RK, et al,. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34: 426-38.
63. Bogle MA., Fractionated mid-infrared resurfacing. Semin Cutan Med Surg 2008; 27: 252-8.
64. Narurkar VA., Nonablative fractional laser resurfacing. Dermatol Clin 2009; 27: 473-8.
65. Sherling M, Friedman PM, Adrian R, et al,. Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatol Surg 2010; 36: 461-9.
66. 2 laser. J Drugs Dermatol 2009; 8: 138-44.
67. Tierney EP, Kouba DJ, Hanke CW., Review of fractional photothermolysis: treatment indications and efficacy. Dermatol Surg 2009; 35: 1445-61.
68. Fisher GH, Kim KH, Bernstein LJ, Geronemus RG., Concurrent use of a handheld forced cold air device minimizes patient discomfort during fractional photothermolysis. Dermatol Surg 2005; 31: 1242-3. (Pubitemid 41587082)
69. Fisher GH, Geronemus RG., Short-term side effects of fractional photothermolysis. Dermatol Surg 2005; 31: 1245-9. (Pubitemid 41587084)
70. Graber EM, Tanzi EL, Alster TS., Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatol Surg 2008; 34: 301-5. (Pubitemid 351316817)
71. Chiu RJ, Kridel RW., Fractionated photothermolysis: the Fraxel 1550-nm glass fiber laser treatment. Facial Plast Surg Clin North Am 2007; 15: 229-37.
72. Tanghetti E., Treatment of Wrinkles and Laxity with the Affirm Anti-Aging System with Multiplex. Westford, MA: Cynosure, Inc; 2007.
73. Hantash BM, Bedi VP, Kapadia B, Rahman Z, et al,. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med 2007; 39: 96-107. (Pubitemid 46411402)
74. Brightman LA, Brauer JA, Anolik R, Weiss E, et al,. Ablative and fractional ablative lasers. Dermatol Clin 2009; 27: 479-89.
75. Tierney EP, Hanke CW., Treatment of Poikiloderma of Civatte with ablative fractional laser resurfacing: prospective study and review of the literature. J Drugs Dermatol 2009; 8: 527-34.
76. 2 laser resurfacing: our experience with more than 2000 treatments. Aesthet Surg J 2009; 29: 317-22.
77. Fitzpatrick RE., Fractional resurfacing: separating fact from fiction. Cosmet Dermatol 2009; 22: 371-6.
78. 2, laser resurfacing for the neck: prospective study and review of the literature. J Drugs Dermatol 2009; 8: 723-31.
79. 2 laser resurfacing: four cases. Lasers Surg Med 2009; 41: 179-84.
80. 2 laser device. J Drugs Dermatol 2008; 7: 774-7.
81. 2 ablative fractional resurfacing. Lasers Surg Med 2008; 40: 381-6.
82. Cho SB, Lee SJ, Kang JM, Kim YK, et al,. The efficacy and safety of 10,600-nm carbon dioxide fractional laser for acne scars in Asian patients. Dermatol Surg 2009; 35: 1955-61.
83. Metelitsa AI, Alster TS., Fractionated laser skin resurfacing treatment complications: a review. Dermatol Surg 2010; 36: 299-306.
84. Chan HH, Manstein D, Yu CS, Shek S, et al,. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers Surg Med 2007; 39: 381-5. (Pubitemid 47041086)
85. 2 resurfacing of photoaged facial skin: preliminary clinical report. J Cosmet Laser Ther 2007; 9: 218-25. (Pubitemid 351182673)